GAMMA Investing
ATHE icon

GAMMA Investing’s Alterity Therapeutics ATHE Stock Holding History

GAMMA Investing’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.2K Sell
1,426
-883
-38% -$4K ﹤0.01% 3630
2026
Q2 		$12.4K Buy
2,309
+453
+24% +$1.97K ﹤0.01% 3098
2026
Q1 		$6.46K Buy
1,856
+1,066
+135% +$3.61K ﹤0.01% 3266
2025
Q4 		$2.43K Buy
+790
New +$3.02K ﹤0.01% 3546

Other funds holding ATHE

Greenleaf Trust
Greenleaf Trust Kalamazoo, Michigan $9.8B AUM 2.94% 1-Year Est. Return
HB Wealth Management
HB Wealth Management Atlanta, Georgia $19.5B AUM 16.96% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Blue Trust Inc
Blue Trust Inc Alpharetta, Georgia $9.5B AUM 13.02% 1-Year Est. Return
CoreCap Advisors
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return
Cranbrook Wealth Management
Cranbrook Wealth Management Bloomfield Hills, Michigan $529M AUM 11.19% 1-Year Est. Return

GAMMA Investing's ATHE Position: Q3 2026 in Review

GAMMA Investing reduced its Alterity Therapeutics (ATHE) stake by 38% in Q3 2026, selling an estimated $4K and leaving 1,426 shares worth $5.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3630.

GAMMA Investing first reported a position in ATHE in Q4 2025 and has held it in 4 quarters since. The position peaked at $12.4K in Q2 2026. 10 funds tracked by Wall St. Rank hold ATHE as of Q3 2026.

  • GAMMA Investing held 1,426 shares of Alterity Therapeutics worth $5.2K as of Q3 2026.
  • GAMMA Investing sold 883 Alterity Therapeutics shares in Q3 2026, an estimated $4K.
  • Alterity Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3630 holding.
  • GAMMA Investing first reported a position in Alterity Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • GAMMA Investing's Alterity Therapeutics position peaked at $12.4K in Q2 2026.
  • 10 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.